Evidence map›Paper›PMID 35499291›Full record

ReviewPhytotherapy research : PTR2022

Emerging trends of edible vaccine therapy for combating human diseases especially COVID-19: Pros, cons, and future challenges.

Fatima Khalid, Reema Tahir, Manahil Ellahi, Nilofer Amir, Syed Faheem Askari Rizvi, Ammarah Hasnain

Open access · bronzeAbstract readReview
In one paragraph

Review in Phytotherapy research : PTR, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Recent development of oral vaccines (Review).Experimental and therapeutic medicine · 2024
    Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Fatima KhalidInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
Reema TahirInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
Manahil EllahiInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
Nilofer AmirInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
Syed Faheem Askari RizviInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.ORCID https://orcid.org/0000-0002-8671-9168
Ammarah HasnainInstitute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
University of Lahore · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The researchers are still doing efforts to develop an effective, reliable, and easily accessible vaccine candidate to protect against COVID-19. As of the August 2020, nearly 30 conventional vaccines have been emerged in clinical trials, and more than 200 vaccines are in various development stages. Nowadays, plants are also considered as a potential source for the production of monoclonal antibodies, vaccines, drugs, immunomodulatory proteins, as well as used as bioreactors or factories for their bulk production. The scientific evidences enlighten that plants are the rich source of oral vaccines, which can be given either by eating the edible parts of plants and/or by oral administration of highly refined proteins. The use of plant-based edible vaccines is an emerging trend as it possesses minimum or no side effects compared with synthetic vaccines. This review article gives insights into different types of vaccines, the use of edible vaccines, advantages of edible vaccines over conventional vaccines, and mechanism of action of edible vaccines. This review article also focuses on the applications of edible vaccines in wide-range of human diseases especially against COVID-19 with emphasis on future perspectives of the use of edible vaccines.

Indexed as

COVID-19VaccinesAdministration, OralHumansPlants, Genetically ModifiedVaccines, EdibleVaccinesVaccines, Edibleconventional vaccineedible vaccineplant-extractsSARS-CoV-2transgenic plant

Identifiers

PMID35499291
PMCPMC9347755
OpenAlexW4225275233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.